Effects of long-term methylcobalamin treatment on the progression of visual field defects in normal-tension glaucoma

Current Therapeutic Research - Clinical and Experimental

Volumn 61, Issue 7, 2000, Pages 443-451

  Yamazaki, Yoshio ^a   Hayamizu, Fukuko ^a   Tanaka, Chizuru ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cox proportional hazards model; Methylcobalamin; Normal tension glaucoma; Visual field defect

Indexed keywords

ANTIGLAUCOMA AGENT; MECOBALAMIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MALE; PRIORITY JOURNAL; VISUAL FIELD DEFECT;

EID: 0033855594     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(00)80027-2     Document Type: Article

References (22)

1. 1. Shiose Y, Kitazawa Y, Tsukahara S, et al. Epidemiology of glaucoma in Japan - a nationwide glaucoma survey. Jpn J Ophthalmol. 1991;35:133-155.
2. 2. Yamazaki Y, Drance SM. The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma. Am J Ophthalmol. 1997;124:287-295.
3. 3. Quigley HA, Nickells RW, Kerrigan LA, et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36: 774-786.
4. 12 in the central nervous system as revealed by congenital defect. Am J Hematol. 1990;34:121-127.
5. 12 improves cognitive disturbance in rodents fed a choline-deficient diet. Pharmacol Biochem Behav. 1992;43:635-639.
6. 6. Yamane K, Usui T, Yamamoto T, et al. Clinical efficacy of intravenous plus oral mecobalamin in patients with peripheral neuropathy using vibration perception thresholds as an indicator of improvement. Curr Ther Res Clin Exp. 1995;56:656-670.
7. 12 analog, methylcobalamin, against glutamate cytotoxicity in cultured cortical neurons. Eur J Pharmacol. 1993;241:1-6.
8. 12 analog, against glutamate-induced neurotoxicity in retinal cell culture. Invest Ophthalmol Vis Sci. 1997;38:848-854.
9. 9. Yamazaki Y, Hayamizu F, Nakagami T, et al. Effect of peroral mecobalamine on the visual field defect in normal-tension glaucoma. Jpn J Clin Ophthalmol. 1998;52:915-919.
10. 10. Heijl A, Lindgren G, Olsson J, et al. Extended empirical statistical package for evaluation of single and multiple fields in glaucoma: StatPac 2. In: Mills RP, Heijl A, eds. Perimetry Update. 1990/1991. Amsterdam, The Netherlands: Kugler; 1991:303-315.
11. 11. Ichikawa H, Shiose Y, Tanabe Y, et al. Effect of Methycobal for visual field change of glaucoma - multicenter clinical trial by controlled study. Journal of the Eye. 1988;5:617-624.
12. 12. Shiose Y. The efficacy of methylcobalamine against low-tension glaucoma. Folia Ophthalmol Jpn. 1988;39:750-756.
13. 13. Kojima Y, Futa R, Furuyoshi N, et al. The long-term effect of mecobalamine on visual function in glaucomatous eyes. Folia Ophthalmol Jpn. 1990;41:1314-1318.
14. 12. Glaucoma. 1992;14:167-170.
15. 15. Mikelberg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas in glaucoma. Am J Ophthalmol. 1986;101:1-6.
16. 16. Schulzer M, Drance SM, Carter CJ, et al. Biostatistical evidence for two distinct chronic open angle glaucoma populations. Br J Ophthalmol. 1990;74:196-200.
17. 17. Shirai H, Sakuma T, Sogano S, Kitazawa Y. Visual field change and risk factors for progression of visual field damage in low tension glaucoma. J Jpn Ophthalmol Soc. 1992;96:352-358.
18. 18. Araie M, Sekine M, Suzuki Y, Koseki N. Factors contributing to the progression of visual field damage in eyes with normal-tension glaucoma. Ophthalmology. 1994;101:1440-1444.
19. 19. Yamazaki Y, Miyamoto S, Hayamizu F, et al. The relationship between visual field defects and clinical factors in normal-tension glaucoma. J Jpn Ophthalmol Soc. 1995;99: 1017-1021.
20. 20. Abedin S, Simmons RJ, Grant WM. Progressive low-tension glaucoma: Treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure. Ophthalmology. 1982;89:1-6.
21. 21. Cartwright MJ, Anderson DR. Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma). Arch Ophthalmol. 1988;106:898-900.
22. 22. Crichton A, Drance SM, Douglas GR, Schulzer M. Unequal intraocular pressure and its relation to asymmetric visual field defects in low-tension glaucoma. Ophthalmology. 1989;96:1312-1314.